AAAAAA

   
Results: 1-22 |
Results: 22
The effect of exogenous luteinizing hormone (LH) on oocyte viability: Evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction
Authors: Balasch, J Creus, M Fabregues, F Civico, S Carmona, F Puerto, B Casamitjana, R Vanrell, JA
Citation: J. Balasch et al., The effect of exogenous luteinizing hormone (LH) on oocyte viability: Evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction, J AS REPROD, 18(5), 2001, pp. 250-256
Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis
Authors: Carmona, F Font, J Azulay, M Creus, M Fabregues, F Cervera, R Puerto, B Balasch, J
Citation: F. Carmona et al., Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis, AM J REPROD, 46(4), 2001, pp. 274-279
Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH
Authors: Balasch, J Vidal, E Penarrubia, J Casamitjana, R Carmona, F Creus, M Fabregues, F Vanrell, JA
Citation: J. Balasch et al., Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH, HUM REPR, 16(8), 2001, pp. 1636-1643
Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation
Authors: Creus, M Ordi, J Fabregues, F Casamitjana, R Vanrell, JA Balasch, J
Citation: M. Creus et al., Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation, HUM REPR, 16(7), 2001, pp. 1347-1352
Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modifiedstep-down regimens
Authors: Balasch, J Fabregues, F Creus, M Puerto, B Penarrubia, J Vanrell, JA
Citation: J. Balasch et al., Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modifiedstep-down regimens, HUM REPR, 16(4), 2001, pp. 652-656
Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol
Authors: Balasch, J Fabregues, F Creus, M Casamitjana, R Puerto, B Vanrell, JA
Citation: J. Balasch et al., Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol, J AS REPROD, 17(10), 2000, pp. 561-565
Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome
Authors: Fabregues, F Balasch, J Creus, M Carmona, F Puerto, B Quinto, L Casamitjana, R Vanrell, JA
Citation: F. Fabregues et al., Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome, J AS REPROD, 17(1), 2000, pp. 13-19
Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: Implications for implantation potential
Authors: Balasch, J Fabregues, F Creus, M Penarrubia, J Vidal, E Carmona, F Puerto, B Vanrell, JA
Citation: J. Balasch et al., Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: Implications for implantation potential, J AS REPROD, 17(1), 2000, pp. 20-27
Serum inhibin B determination is predictive of successful testicular spermextraction in men with non-obstructive azoospermia
Authors: Ballesca, JL Balasch, J Calafell, JM Alvarez, R Fabregues, F de Osaba, MJM Ascaso, C Vanrell, JA
Citation: Jl. Ballesca et al., Serum inhibin B determination is predictive of successful testicular spermextraction in men with non-obstructive azoospermia, HUM REPR, 15(8), 2000, pp. 1734-1738
Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment
Authors: Penarrubia, J Balasch, J Fabregues, F Carmona, F Casamitjana, R Moreno, V Calafell, JM Vanrell, JA
Citation: J. Penarrubia et al., Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment, HUM REPR, 15(7), 2000, pp. 1499-1504
Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response
Authors: Manau, D Balasch, J Jimenez, W Fabregues, F Civico, S Casamitjana, R Creus, M Vanrell, JA
Citation: D. Manau et al., Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response, HUM REPR, 15(6), 2000, pp. 1295-1299
Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome
Authors: Creus, M Penarrubia, J Fabregues, F Vidal, E Carmona, F Casamitjana, R Vanrell, JA Balasch, J
Citation: M. Creus et al., Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome, HUM REPR, 15(11), 2000, pp. 2341-2346
Increasing the daily dose of recombinant follicle stimulating hormone (Puregon((R))) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation
Authors: Out, HJ Braat, DDM Lintsen, BME Gurgan, T Bukulmez, O Gokmen, O Keles, G Caballero, P Gonzalez, JM Fabregues, F Balasch, J Roulier, R
Citation: Hj. Out et al., Increasing the daily dose of recombinant follicle stimulating hormone (Puregon((R))) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation, HUM REPR, 15(1), 2000, pp. 29-35
Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesterone
Authors: Fabregues, F Balasch, J Manau, D Creus, M Jimenez, W Carmona, F Casamitjana, R Vanrell, JA
Citation: F. Fabregues et al., Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesterone, ACT OBST SC, 79(7), 2000, pp. 564-569
Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)
Authors: Balasch, J Reverter, JC Creus, M Tassies, D Fabregues, F Carmona, F Font, J Vanrell, JA
Citation: J. Balasch et al., Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome), HUM REPR, 14(8), 1999, pp. 1956-1959
Recurrent empty follicle syndrome successfully treated with recombinant human chorionic, gonadotrophin
Authors: Penarrubia, J Balasch, J Fabregues, F Creus, M Civico, S Vanrell, JA
Citation: J. Penarrubia et al., Recurrent empty follicle syndrome successfully treated with recombinant human chorionic, gonadotrophin, HUM REPR, 14(7), 1999, pp. 1703-1706
Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome
Authors: Fabregues, F Balasch, J Gines, P Manau, D Jimenez, W Arroyo, V Creus, M Vanrell, JA
Citation: F. Fabregues et al., Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome, AM J GASTRO, 94(4), 1999, pp. 994-999
Adrenomedullin and nitric oxide in menstrual and in vitro fertilization cycles. Relationship to estradiol
Authors: Manau, D Balasch, J Jimenez, W Fabregues, F Casamitjana, R Creus, M Arroyo, V Vanrell, JA
Citation: D. Manau et al., Adrenomedullin and nitric oxide in menstrual and in vitro fertilization cycles. Relationship to estradiol, ACT OBST SC, 78(7), 1999, pp. 626-631
Haematocrit, leukocyte and platelet counts and the severity of the ovarianhyperstimulation syndrome
Authors: Fabregues, F Balasch, J Manau, D Jimenez, W Arroyo, V Creus, M Rivera, F Vanrell, JA
Citation: F. Fabregues et al., Haematocrit, leukocyte and platelet counts and the severity of the ovarianhyperstimulation syndrome, HUM REPR, 13(9), 1998, pp. 2406-2410
Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles
Authors: Penarrubia, J Balasch, J Fabregues, F Creus, M Casamitjana, R Ballesca, JL Puerto, B Vanrell, JA
Citation: J. Penarrubia et al., Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles, HUM REPR, 13(12), 1998, pp. 3315-3318
Integrin expression in normal and out-of-phase endometria
Authors: Creus, M Balasch, J Ordi, J Fabregues, F Casamitjana, R Quinto, L Coutifaris, C Vanrell, JA
Citation: M. Creus et al., Integrin expression in normal and out-of-phase endometria, HUM REPR, 13(12), 1998, pp. 3460-3468
Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome
Authors: Balasch, J Fabregues, F Arroyo, V
Citation: J. Balasch et al., Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome, HUM REPR, 13(10), 1998, pp. 2718-2730
Risultati: 1-22 |